CytRx Corporation (OTCMKTS:CYTR) Stock On Radar After Patent News
Biopharmaceutical innovator CytRx Corporation (OTCMKTS:CYTR) was in the news yesterday after it made a major new announcement with regards to the receipt of a key patent. For an innovative company that can often be seen as a significant development. Trading Data On Wednesday, CYTR stock fell 2.77% to $0.0824 with 23.32K shares, compared to volume of 66.64K shares. The stock moved within a range of $0.0787 – 0.0897 after opening…